Glenview Trust’s Amdocs DOX Stock Holding History

Glenview Trust’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,302	Closed	-$326K	–	423
2021 Q3	$326K	Hold	4,302	–	–	0.01%	331
2021 Q2	$333K	Hold	4,302	–	–	0.01%	340
2021 Q1	$302K	Buy	+4,302	New	+$325K	0.01%	335

Other funds holding DOX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Glenview Trust's DOX Position: Q4 2021 in Review

Glenview Trust sold out of Amdocs (DOX) in Q4 2021, closing a stake of 4,302 shares — an estimated $326K sold.

Glenview Trust first reported a position in DOX in Q1 2021 and held it in 3 quarters. The position peaked at $333K in Q2 2021. 416 funds tracked by Wall St. Rank hold DOX as of Q4 2021.

Glenview Trust reported no remaining Amdocs position as of Q4 2021 after selling out during the quarter.
Glenview Trust sold 4,302 Amdocs shares in Q4 2021, an estimated $326K.
Glenview Trust first reported a position in Amdocs in Q1 2021 and held it in 3 quarters.
Glenview Trust's Amdocs position peaked at $333K in Q2 2021.
416 funds tracked by Wall St. Rank held Amdocs as of Q4 2021.

Based on Glenview Trust's 13F filing for Q4 2021, filed 10 Feb 2022.